Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
fda bamlanivimab | 1.45 | 0.2 | 2364 | 56 | 16 |
fda | 0.37 | 0.2 | 9303 | 12 | 3 |
bamlanivimab | 0.69 | 0.4 | 6633 | 58 | 12 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda bamlanivimab | 0.27 | 0.7 | 2556 | 92 |
bamlanivimab and etesevimab fda | 0.13 | 0.3 | 1828 | 28 |
bamlanivimab and etesevimab fda eua | 0.27 | 1 | 4632 | 38 |
bamlanivimab etesevimab fda | 1.85 | 0.8 | 8935 | 21 |
bamlanivimab fda approval | 0.17 | 0.4 | 7166 | 46 |
fda fact sheet bamlanivimab etesevimab | 0.38 | 0.3 | 10000 | 30 |
fda eua bamlanivimab | 0.41 | 0.2 | 8828 | 42 |
what is bamlanivimab and etesevimab | 0.05 | 0.3 | 2385 | 85 |
bamlanivimab and etesevimab brand name | 1.67 | 0.4 | 8486 | 56 |
bamlanivimab and etesevimab side effects | 1.24 | 0.7 | 7686 | 68 |
atoltivimab maftivimab and odesivimab-ebgn | 1.16 | 0.6 | 2416 | 26 |